Regulatory Roundup: Oregon Targets GNC In BMPEA Complaint, Spiked Products In Imports
This article was originally published in The Tan Sheet
Oregon’s lawsuit argues GNC should not have waited for FDA warnings to remove products containing BMPEA and picamilon and violated state law by marketing products containing the ingredients at any time; and FTC “believes it is necessary for the agency to begin collecting information from e-cigarette marketers.”
You may also be interested in...
State attorneys general largely are discriminating good from bad supplement industry actors, says former Maryland AG Doug Gansler following the annual meeting of the Western Attorneys General. State officials' brighter take on supplement firms stems from industry outreach and education efforts.
The termination of the Aurobindo-Sandoz deal isn’t perhaps all bad news for the Indian firm and the flip side may be an improved balance sheet, according to some analysts. But the resolution of compliance issues at manufacturing facilities remains critical.
“When COVID-19 hit, we really decided to accelerate plans,” says BlueWillow CEO Dave Peralta. NanoBio Protect contains OTC monograph ingredient benzalkonium chloride in a proprietary nanotechnology, alcohol-free formulation to help reduce germs on skin inside and around the nose that could cause infections.